Abstract PO3-20-06: TRUDI: A Phase II Study of Neoadjuvant TRastuzumab Deruxtecan and Durvalumab for Stage III HER2-expressing Inflammatory Breast CancerPaolo Tarantino,Samuel Niman,Antonio Giordano,Faina Nakhlis,Jennifer R. Bellon,Wendy A. Woodward,Azadeh Nasrazadani,Sadia Saleem,Anthony Lucci,Michelle K. DeMeo,Naoto T. Ueno,Sara M. Tolaney,Vicente Valero,Meredith M. Regan,Rachel M. Layman,Filipa LynceCancer research(2024)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要